On 5 July 2023, Mr. Xu Jinghe, Deputy Commissioner of China’s National Medical Products Administration (NMPA), during the press conference “Talk by Authorities” illustrated [.....]
On 18 March 2021, the National Medical Products Administration issued the revised version of the Regulations on the Supervision and Administration of Medical Devices. [.....]
On March 30, the National Medical Products Administration (NMPA) and the Standardization Administration of China (SAC) jointly issued the Opinions on Further Promoting the [.....]
At the end of February 2021, the National Medical Products Administration (NMPA) released the "Annual Report on the Management of China's Medical Device Standards [.....]
On 2nd August CFDA released notice on registered information management for medical device production and operation license. The notice required the provincial level CFDA [.....]
On 2nd August, CFDA released management of imported medical devices agent (draft) for public comment. The draft defined clearly the requirements for agent and [.....]
On 25th June, the ministry of justice published the amended regulation on supervision and management of medical devices (draft) and called for public comments. [.....]
Sponsored by the COCIR, the seminar was held to facilitate communication between Chinese and Foreign medical device stakeholders in Tsinghua University on September 8, [.....]
The General Office of the State Council issued the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry” which aims to promote [.....]
The General Office of the State Council issued the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry” which aims to promote [.....]
